Strides Pharma has agreed to a $750,000 class action settlement to resolve claims that its testosterone gel products were contaminated with benzene, a known carcinogen.
The Strides settlement benefits consumers who purchased Strides testosterone gel between June 1, 2022, and July 31, 2025.
According to a class action lawsuit, Strides’ testosterone gel products were contaminated with benzene, a known human carcinogen, during the manufacturing process due to Strides’ alleged negligence. Plaintiffs in the case say they would not have purchased the contaminated testosterone gel products if they had known the truth about Strides’ manufacturing process.
Strides Pharma is a global pharmaceutical company that manufactures and sells generic and branded drugs.
Strides has not admitted any wrongdoing but agreed to resolve these allegations with a class action settlement.
Under the terms of the Strides settlement, class members can receive a cash payment based on the amount they paid for Strides gel and the date of purchase.
Class members who purchased testosterone gel can receive the following reimbursements for their out-of-pocket payments: 40% from June 1, 2022, through Dec. 31, 2023; 75% from Jan. 1, 2024, through Dec. 31, 2024; and 100% from Jan. 1, 2025, through July 31, 2025.
The settlement also provides a minimum baseline payment of $3.50 per prescription, as further modified by the percentages based on purchase date.
The deadline for exclusion and objection is Aug. 17, 2026.
The final approval hearing for the Strides testosterone gel settlement is scheduled for Nov. 19, 2026.
The deadline to submit a claim with the class action settlement is Sept. 16, 2026.
Who’s Eligible
The class action settlement benefits consumers who purchased Strides testosterone gel between June 1, 2022, and July 31, 2025.
Potential Award
Varies
Proof of Purchase
NDC number or other manufacturer identification
Claim Form
NOTE: If you do not qualify for this settlement do NOT file a claim.
Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.
Claim Form Deadline
09/16/2026
Case Name
Painter v. Strides Pharma Inc., Case No. 7:25-CV-4189, in the U.S. District Court for the Southern District of New York
Final Hearing
11/19/2026
Settlement Website
Claims Administrator
Painter v. Strides Pharma Inc. Settlement
P.O. Box 301134
Los Angeles, CA 90030-1134
[email protected]
888-808-7024
Class Counsel
Aaron K. Block
Max Marks
THE BLOCK FIRM LLC
Defense Counsel
Douglas Tween
John Eichlin
LINKLATERS LLP
Read About More Class Action Lawsuits & Class Action Settlements:
- $60.5M Tinder Plus and Gold discrimination class action settlement
- $2M Bestway spa pump class action settlement
- BMW shark-fin antenna class action settlement
- $31.5M Flagstar Bank data breach class action settlement
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2026 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.